Vaccine Hesitancy Trends from 2019 to 2022 Evaluated
Drug Topics
OCTOBER 21, 2022
As vaccine hesitancy grows, fewer children are receiving routine childhood vaccines.
2019 Related Topics 
Measles Cases in the US Increased Significantly in 2024
Drug Topics
APRIL 12, 2024
Since a 2019 measles outbreak, the CDC has seen an increasing number of cases in the US.
503 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Evaluating Changes in Systemic Anticancer Therapy Use Between 2015 and 2019
Drug Topics
NOVEMBER 11, 2022
While the use of chemotherapy at end of life is decreasing, the use of immunotherapy is increasing.
Chemotherapy 247
247 Chemotherapy 247
247 
Cultural, Health System Barriers Impact HPV Vaccination Rates
Drug Topics
JANUARY 3, 2025
Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.
Vaccines 281
281 Vaccines 281
281 
Veterans Mental Health Care Improvement Act of 2019 Expands Access
Pharmacy Times
FEBRUARY 23, 2024
Four years after congress passed it, the Hannon Act is helping veterans get better care
144 
CDC: Uninsured rate fell by 26% between 2019 and 2023
Fierce Healthcare
JUNE 18, 2024
The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention. | The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention.
113 
STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes
STAT
MARCH 27, 2025
customers six years ago, but did not report any profits from those sales on its 2019 tax returns because all of the income was supposedly earned offshore, according to an investigation by the Democratic staff of the Senate Finance Committee. In what one U.S. for 2018 and 2020.
GARDASIL 9 Shows Positive Results in Phase 3 Study Against HPV-Related Cancers
Drug Topics
SEPTEMBER 5, 2023
According to the Centers for Disease Control and Prevention, tens of thousands of HPV-related cancer diagnoses were given per year from 2015 to 2019.
247 
Digital health funding hit $5.7B through June, on track to surpass 2019 and 2023, Rock Health reports
Fierce Healthcare
JULY 8, 2024
digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year. | digital health startups pulled in $5.7
138 
Google’s Dr. Karen says farewell
STAT
MAY 6, 2025
DeSalvo, who likes to introduce herself as Dr. Karen, joined Google in 2019 and became the face of the company’s health efforts in 2021 when VP of health David Feinberg left to join EHR company Cerner (Now part of Oracle Health). Sign up to get it delivered in your inbox every Tuesday and Thursday.
Cerner 98
98 Cerner 98
98 
Gilead’s CMO to depart next year
PharmaVoice
JULY 19, 2024
Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.
147 
Lawmakers mull lifting ban on physician-owned hospitals as doc lobbying groups claim major cost savings
Fierce Healthcare
OCTOBER 19, 2023
billion in savings across 20 of Medicare’s most expensive conditions in 2019— tho | Lobbying groups in favor of overturning the ban on new physician-owned hospitals outlined broad cost savings if 2019's Medicare patients were treated at such facilities instead of a traditional hospital.
Hospitals 144
144 Hospitals 144
144 
STAT+: Immunovant replaces CEO, makes other changes as Roivant tightens control
STAT
APRIL 21, 2025
Immunovant was spun out of Roivant in 2019 to develop a pipeline of drugs to treat autoimmune disorders. Immunovant CFO Renee Barnett is also leaving, to be replaced by Tiago Girao, currently the CFO of Televant, another Roivant affiliate company. Continue to STAT+ to read the full story…
88 
GLP-1s Associated With Increased Risk of Neovascular Age-Related Macular Degeneration
Drug Topics
JUNE 6, 2025
Prevalence of Age-Related Macular Degeneration in the US in 2019. Published online June 05, 2025. doi:10.1001/jamaophthalmol.2025.1455 2025.1455 2. Rein DB, Wittenborn JS, Burke-Conte Z, et al. JAMA Ophthalmol. 2022;140(12):1202–1208. doi:10.1001/jamaophthalmol.2022.4401
Compounding 282
282 
STAT+: Generic drugmakers win a long-running battle with California over a law to ban pay-to-delay deals
STAT
FEBRUARY 18, 2025
District Court Judge Troy Nunley determined that the state law, which was enacted in 2019, violated the Dormant Commerce Clause of the U.S. In his ruling , U.S. Constitution because it would extend to pay-to-delay agreements that happened outside of California and, therefore, attempted to regulate interstate commerce.
STAT+: As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse
STAT
SEPTEMBER 23, 2024
In just four years from the beginning of 2019 through 2022, according to the report, the number of Medicare patients receiving RPM increased tenfold, from 55,000 to 570,000. Remote patient monitoring has exploded since the pandemic. Medicare Advantage use increased 14 times over. Medicare Advantage use increased 14 times over.
139 
STAT+: AI versus AI: The emerging arms race over health insurance denials
STAT
DECEMBER 12, 2024
The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. Like many Americans, Holden Karau said she was fed up with health insurance.
Insurance 145
145 Insurance 145
145 
Study Finds Significant Drop in Vaccine Confidence During COVID-19 Pandemic
Pharmacy Times
NOVEMBER 16, 2022
In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.
Vaccines 132
132 Vaccines 132
132 
Independent Pharmacists’ Unique Role During Disaster Management Efforts
Drug Topics
JUNE 11, 2025
August 28, 2019. Role of pharmacist in disaster management: a quantitative content analysis approach. Innov Pharm. 2021;12(4):10.24926/iip.v12i4.4359. doi:10.24926/iip.v12i4.4359 5. Safe drug use after a natural disaster. Accessed April 10, 2025. Wang X, Liu K, Shirai K, et al. Prevalence and trends of polypharmacy in U.S. adults, 1999-2018.
Digital health investments shift to disease treatment, workflow solutions and VBC in Q3: Rock Health
Fierce Healthcare
OCTOBER 2, 2023
billion across 119 deals, the second-lowest quarter by funding total since the fourth quarter of 2019, Rock Health reports. Digital health founders and investors continue to face a tighter funding cycle with fewer deals and lower check sizes. | In Q3 2023, U.S. digital health startups raised $2.5
140 
Statin statistics 2025
The Checkup by Singlecare
JUNE 5, 2025
American Heart Association , 2019) All races are affected by high cholesterol, without significant differences among races in the prevalence of high total cholesterol. As of 2019, 35% of Americans were taking some kind of statin to treat their cholesterol levels. CDC 2020) Statins use in the U.S. In the U.S.,
Mayo Clinic 52
52 
Done deal: Pfizer completes $43B acquisition of Seagen, doubling its oncology pipeline
Fierce Pharma
DECEMBER 14, 2023
Pfizer’s $43 billion acquisition of Seagen is in the books, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019. The buyout of the antibody-drug conjugate specialist has doubled Pfizer’s pipeline to 60 programs.
145 
How CymaBay overcame a NASH failure for another shot at liver disease success
PharmaVoice
AUGUST 2, 2023
The biotech’s 2019 trial halt was a major disappointment in NASH, but a turnaround has shown late-stage potential in another liver disease with unmet needs.
130 
Fierce Healthcare - Untitled Article
Fierce Healthcare
MAY 2, 2025
A collaboration between Express Scripts and Prime Therapeutics from late 2019 is under the legal microscope again, this time by the Michigan Attorney General. The state says the partnership amounted to collusion and led to pharmacy deserts across the state.
88 
Youth vaping continues its tumble from a Juul-fueled high
STAT
SEPTEMBER 5, 2024
Around 6% of middle and high school students used vapes in 2024, down from 8% last year, and a record high of 20% in 2019, according to a survey released Thursday by the FDA and the CDC. The number of U.S. The vape brand Juul fueled this surge, but has since receded in popularity after FDA actions and legal challenges.
FDA 139
139 FDA 139
139 
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 2, 2025
A new analysis of 70 hospitals nurse staffing from 2019 to 2022 found an uptick in pressure ulcers tied to heightened levels of agency and overtime labor.
Hospitals 115
115 Hospitals 115
115 
STAT+: SEC charges former CEO of pain relief device company with $41 million fraud
STAT
DECEMBER 20, 2023
Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.
Insurance 137
137 Insurance 137
137 
FDA Approves IVIG for Pediatric Patients Aged 2 and Older With Primary Humoral Immunodeficiency
Pharmacy Times
DECEMBER 13, 2023
Bivigam was initially approved by the FDA in May 2019 for the treatment of primary humoral immunodeficiency, including a group of genetic disorders.
FDA 123
123 FDA 123
123 
Vanda's jet-lag approval hopes for Hetlioz quashed with FDA hearing rejection
Fierce Pharma
MARCH 5, 2024
Vanda has been waiting years for an FDA hearing to contest the agency’s 2019 rejection of its sleep drug Hetlioz in jet lag disorder. Vanda has been waiting years for an FDA hearing to contest the agency’s 2019 rejection of its sleep drug Hetlioz in jet lag disorder. regulator, the FDA has crushed Vanda’s bid.
FDA 113
113 FDA 113
113 
STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
STAT
SEPTEMBER 12, 2024
After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis dedicated himself to eradicating it. Pirovolakis, a Canadian IT director, recruited academics and raised $3 million to design a gene therapy.
145 
Direct-acting Antivirals for Hepatitis C Infection Are Underused in the US, Study Finds
Pharmacy Times
DECEMBER 15, 2022
While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.
123 
Healthcare bankruptcy filings slow in 2024, largely driven by middle-market companies, analysis finds
Fierce Healthcare
AUGUST 16, 2024
The report analyzed healthcare sector Chapter 11 bankruptcy filings from 2019 through mid-2024. Healthcare bankruptcy filings have slowed over the past three quarters, according to a new analysis by healthcare restructuring advisory firm Gibbins Advisors. |
121 
The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs
The FDA Law Blog
APRIL 8, 2025
Since 2019, when DPD took over this process, the Division has published more than 600 ANDA withdrawals at the request of generic drug manufacturers. Processing voluntary ANDA withdrawals under 21 C.F.R. 314.150(c). Managing the process of issuing Covered Product Authorizations (CPAs) under the CREATES Act.
FDA 144
144 
Pandemic policies have fewer adults skipping medical care due to cost
Fierce Healthcare
JULY 8, 2024
Nearly 5 million fewer people delayed care from 2019 to 2022, a study from the Urban Institute with funding from the Robert Wood Johnson Foundation revealed. Pandemic-era policies appear to have helped almost 5 million people access necessary medical care that they otherwise may not have been able to, a recent report shows.
119 
Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection
Fierce Pharma
APRIL 23, 2024
Dating to a 2019 clinical hold of a phase 3 trial, getting its gene therapy ra | Dating to a 2019 clinical hold, getting its gene therapy pz-cel across the FDA finish line has been a challenge for troubled Abeona Therapeutics. Now the wait continues as the FDA has rejected the treatment due to CMC issues.
FDA 108
108 FDA 108
108 
Opinion: Independent doctors like me are becoming an endangered species
STAT
FEBRUARY 15, 2024
More than 100,000 doctors have left private practice and become employees of hospitals and other corporate entities since 2019. Today, nearly three in four physicians are employees of larger health care entities or other corporations — a record high.
Hospitals 145
145 Hospitals 145
145 
STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud
STAT
MARCH 7, 2024
Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. STAT published new details about the Stimwave story in May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019.
Insurance 131
131 Insurance 131
131 
FDA sends warning letter to KVK-Tech manufacturing facility
European Pharmaceutical Review
FEBRUARY 3, 2025
The US Food and Drug Administration (FDA) has sent a warning letter to KVK-Techs drug manufacturing facility following an inspection in April 2019. The document identified significant violations of current good manufacturing practice (cGMP) regulations for finished pharmaceuticals.
FDA 88
88 
There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it
STAT
AUGUST 21, 2024
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer.
29 
Walgreens releases 2023-2024 flu index
Drug Store News
OCTOBER 20, 2023
Flu activity is 66% lower than this time last year, but it is 34% higher when looking at pre-pandemic seasons, such as 2018-2019.
116 
STAT+: Vida Ventures brings in new leaders after co-founders’ departure
STAT
APRIL 2, 2025
Kim and Jail have both been with Vida since 2019 and previously worked with Belldegrun at Kite Pharma. Cohen will steer public market investing — a first for the firm — while Goodman will work on creating and financing private startups. They join Helen Kim and Rajul Jain on the firm’s leadership team.
109 
Is the future of AI in health care just a lot of hype?
STAT
OCTOBER 10, 2024
Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about AI’s capabilities. Now he’s teamed up with his Ph.D. student Kapoor to publish the book “ AI Snake Oil ,” which came out Sep.
Hospitals 140
140 Hospitals 140
140 
Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
STAT
MARCH 13, 2023
Meanwhile, medical notes in June 2019 showed Walter’s pain was maxing out the scales and that she could not dress herself, go to the bathroom, or even push a walker without help. Read the rest…
Nursing Homes 145
145 
Routine vaccinations drop among U.S. kindergartners for the third year in a row
STAT
JANUARY 12, 2023
Vaccinations among children remain high, but the trend — with coverage dropping from about 95% in the 2019-2020 school year to 94% in 2020-2021 to 93% in 2021-2022, according to the data released Thursday — has health officials concerned. The percentage of U.S.
Vaccines 145
145 Vaccines 145
145 
Let's personalize your content